comparemela.com

Dermatology Resident News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CeraVe Helps Expand Dermatology Residency Training Program at the George Washington University School of Medicine and Health Sciences

New Google AI Tool Could Potentially Identify Skin Conditions

New Google AI Tool Could Potentially Identify Skin Conditions Image Credit: Shutterstock.com / Andrey Popov Google’s new Dermatology Assist app identifies skin and nail conditions prompting users to seek a professional medical diagnosis.  Skin conditions affect around 1.9 billion people, and a shortfall of dermatologists means that often conditions have to be diagnosed and treated by general practitioners who may not always be best equipped to identify such conditions. Help could be at hand, enabling members of the general public to self-identify skin and nail conditions, prompting them to seek specialized medical treatment. Google has announced an AI tool named Dermatology Assist designed to help users potentially spot dermatological conditions based upon images they upload themselves.

Soliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic Scars

Share this article Share this article HOUSTON, Jan. 26, 2021 /PRNewswire/  Soliton, Inc., (Nasdaq: SOLY) ( Soliton or the Company ), a medical device company with a novel and proprietary platform technology, today announced it has entered into a collaboration with the US Navy to conduct a multi-treatment proof-of-concept clinical study to evaluate the safety, and efficacy of multiple treatments with Soliton s Rapid Acoustic Pulse (RAP) device for the improvement in the appearance of fibrotic scars. The study will be a US-based, single-center, prospective trial, examining a maximum of 25 patients. We are extremely pleased to collaborate with the US Navy and investigate the safety and efficacy of our RAP device in improving the appearance of fibrotic scars, commented Brad Hauser, Soliton CEO and President. The results from our previous proof-of-concept Keloid and Hypertrophic Scar trial were extremely encouraging, as the RAP device demonstrated reductions in both the volume o

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.